Release Date: 22/12/20 09:43 Summary: Resignation of Managing Director and Chief Executive Officer Price Sensitive: Yes Download Document 99.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%